- Home
- ARVN vs EVV Comparison
ARVN vs EVV Comparison
Compare ARVN & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- EVV
- Stock Information
- Founded
- ARVN 2015
- EVV 2003
- Country
- ARVN United States
- EVV United States
- Employees
- ARVN N/A
- EVV N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- EVV Finance/Investors Services
- Sector
- ARVN Health Care
- EVV Finance
- Exchange
- ARVN Nasdaq
- EVV Nasdaq
- Market Cap
- ARVN 1.2B
- EVV 1.2B
- IPO Year
- ARVN 2018
- EVV N/A
- Fundamental
- Price
- ARVN $7.02
- EVV $10.01
- Analyst Decision
- ARVN Buy
- EVV
- Analyst Count
- ARVN 13
- EVV 0
- Target Price
- ARVN $34.42
- EVV N/A
- AVG Volume (30 Days)
- ARVN 3.5M
- EVV 323.7K
- Earning Date
- ARVN 05-06-2025
- EVV 01-01-0001
- Dividend Yield
- ARVN N/A
- EVV 9.66%
- EPS Growth
- ARVN N/A
- EVV N/A
- EPS
- ARVN N/A
- EVV N/A
- Revenue
- ARVN $263,399,999.00
- EVV N/A
- Revenue This Year
- ARVN N/A
- EVV N/A
- Revenue Next Year
- ARVN $7.99
- EVV N/A
- P/E Ratio
- ARVN N/A
- EVV N/A
- Revenue Growth
- ARVN 235.54
- EVV N/A
- 52 Week Low
- ARVN $6.88
- EVV $8.52
- 52 Week High
- ARVN $41.34
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- ARVN 23.50
- EVV 41.54
- Support Level
- ARVN $8.51
- EVV $10.00
- Resistance Level
- ARVN $9.17
- EVV $10.18
- Average True Range (ATR)
- ARVN 0.55
- EVV 0.08
- MACD
- ARVN -0.05
- EVV -0.00
- Stochastic Oscillator
- ARVN 5.24
- EVV 16.67
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure among others.